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Background: Sickle cell disease (SCD) is a hematological genetic disease affecting over 25 million people worldwide. The
main clinical manifestations of SCD, hemolytic anemia and vaso-occlusion, lead to chronic pain and organ damages. With recent
advances in childhood care, high-income countries have seen SCD drift from a disease of early childhood mortality to a neglected
chronic disease of adulthood. In particular, coordinated, preventive, and comprehensive care for adults with SCD is largely
underresourced. Consequently, patients are left to self-manage. Mobile health (mHealth) apps for chronic disease self-management
are now flooding app stores. However, evidence remains unclear about their effectiveness, and the literature indicates low user
engagement and poor adoption rates. Finally, few apps have been developed for people with SCD and none encompasses their
numerous and complex self-care management needs.
Objective: This study aimed to identify factors that may influence the long-term engagement and user adoption of mHealth
among the particularly isolated community of adult patients with SCD living in low-prevalence, high-income countries.
Methods: Semistructured interviews were conducted. Interviews were audiotaped, transcribed verbatim, and analyzed using
thematic analysis. Analysis was informed by the Braun and Clarke framework and mapped to the COM-B model (capability,
opportunity, motivation, and behavior). Results were classified into high-level functional requirements (FRs) and nonfunctional
requirements (NFRs) to guide the development of future mHealth interventions.
Results: Overall, 6 males and 4 females were interviewed (aged between 21 and 55 years). Thirty FRs and 31 NFRs were
extracted from the analysis. Most participants (8/10) were concerned about increasing their physical capabilities being able to
stop pain symptoms quickly. Regarding the psychological capability aspects, all interviewees desired to receive trustworthy
feedback on their self-care management practices. About their physical opportunities, most (7/10) expressed a strong desire to
receive alerts when they would reach their own physiological limitations (ie, during physical activity). Concerning social
opportunity, most (9/10) reported wanting to learn about the self-care practices of other patients. Relating to motivational aspects,
many interviewees (6/10) stressed their need to learn how to avoid the symptoms and live as normal a life as possible. Finally,
NFRs included inconspicuousness and customizability of user experience, automatic data collection, data shareability, and data
privacy.
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Conclusions: Our findings suggest that motivation and engagement with mHealth technologies among the studied population
could be increased by providing features that clearly benefit them. Self-management support and self-care decision aid are patients’
major demands. As the complexity of SCD self-management requires a high cognitive load, pervasive health technologies such
as wearable sensors, implantable devices, or inconspicuous conversational user interfaces should be explored to ease it. Some of
the required technologies already exist but must be integrated, bundled, adapted, or improved to meet the specific needs of people
with SCD.
(JMIR Hum Factors 2020;7(1):e14599)  doi: 10.2196/14599
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Introduction
A Tsunami of Mobile Health Apps for Chronic Disease
Self-Management
Mobile health (mHealth) apps are flooding the app stores, with
200 new apps each day [1]. Many apps can significantly improve
health outcomes [2,3] by supporting people with diverse medical
conditions [4]. However, little is known about the app usage
frequency and long-term engagement among chronic patients
[5,6]. Indeed, Robbins et al [7] underlined that people who
would most benefit from such apps underuse them. To promote
mHealth usage, app developers need to comprehend what could
motivate patients to engage in mHealth [8]. The theory of
reasoned action [9,10] demonstrates that the likelihood to engage
in a specific behavior is a function of the motivation to perform
it. Authors, such as Coa et al [11], confirmed that calculating
baseline motivation levels could predict retention rates for apps.
To influence people’s motivation through persuasion rather than
coercion, the field of persuasive technology offers novel
user-centered approaches (ie, cocreation) [12-18].
The Case of Sickle Cell Disease: One of the World’s
Most Neglected Chronic Diseases
In this paper, we focus on sickle cell disease (SCD). SCD is the
most common monogenic blood disorder in the world. Studies
approximate 400,000 neonates per year [19,20] and between
25 and 100 million patients worldwide living with the disease
[21,22]. In this study, we specifically target populations from
low-prevalence areas of high-income countries. In these settings,
the disease is underresourced, research-derived evidence is
lacking, and patients are particularly isolated [23].
SCD is still a serious illness. Hemolytic anemia and
vaso-occlusive pain crises (VOCs) are the hallmarks of the
disease [24]. Patients may suffer severe and potentially lethal
complications [25]. Hydroxyurea, the preferred
disease-modifying treatment, is underutilized and not effective
for every patient [26]. Furthermore, the only curative option,
bone marrow transplant, is largely inaccessible [27].
However, public health interventions such as regional screening
programs, preventive care, coordinated care and comprehensive
care plans have been introduced in the major regions of
high-prevalence, high-income countries [28]. These
interventions drastically reduced early childhood mortality and
made SCD shift to a chronic disease of adulthood [29].
Nevertheless, such programs have not been implemented widely
and remain virtually absent in most low-prevalence, high-income
countries [20,30]. In addition, there are few trained physicians
and access to specialized health care is suboptimal [31-33].
Indeed, patients with SCD are particularly prone to confront
stigmatization, to suffer unequal treatment, and to experience
health care injustice (ie, perception as drug seekers) [33-35].
This often leads to mistrust between patients and health care
providers [36,37]. As several studies demonstrated [38-44],
when patients arrive in emergency departments, the lack of
objective hematological findings and little awareness of those
findings make health care providers suspicious of the veracity
of a VOC. This distrust makes the SCD community infamously
difficult to recruit in research initiatives and hard to engage in
interactions with medical providers, and the distrust also lowers
adherence to medical recommendations [36,45-48].
Consequently, most patients are left to self-manage and rely on
poor-quality health care, and they report low levels of quality
of life [49,50].
Persuasive Mobile Health Interventions to Support an
Undersupported Population
To make matters worse, as several studies demonstrated [51,52],
self-care management is challenging for people with SCD.
Indeed, managing the numerous potential precipitating factors
of VOCs requires high levels of self-efficacy [52-55].
Well-known triggers [56] include inadequate diet, stress (ie,
exertional, oxidative, and psychological), infections,
inflammations, acidosis, dehydration, fatigue, chronic hemolysis,
hypoxia, smoke inhalation, alcohol intoxication, pregnancy,
and environmental factors (ie, altitude, pollution, extremes of
temperature, climate, and wind speed). As a consequence, SCD
self-care management practices require patients to pay special
attention to everything. In a usual day, extreme temperature
changes, bad weather, and high altitudes should be avoided;
eating behaviors should be optimized with regular hydration;
exercise should be moderate and not exhausting; rest should be
sufficient; prescribed drugs should be taken; and stress should
be managed and avoided as much as possible [50,57-59].
Finally, as in all diseases, socioeconomic factors such as
education levels, occupation, or income play an important role
in empowering patients [60,61].
mHealth apps, because of their relatively low cost and wide
reach, could offer a potential route to support patients’ numerous
self-management tasks [62]. Little work has been done to design
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tailored mHealth interventions for the comprehensive
self-management needs of patients with SCD [63,64]. Today,
most existing apps and research focuses on medication
adherence [65]. Consequently, solutions encompassing the
multiple components of SCD self-management are absent. Shah
et al [66] suggested that patients with SCD could be interested
in such tools. However, as with other chronic diseases, little is
known about those patients’ mHealth app adoption and
long-term engagement.
This paper is the last component of a study from which
preliminary results have already been published [67]. This prior
publication was the first to elaborate on mHealth long-term
engagement among patients with SCD. The authors explored
common motivational patterns for mHealth use between patients
with SCD, patients with diabetes, and healthy people.
This paper focuses on adults with SCD living in low-prevalence
areas of high-income countries. It was aimed to assess patients’
requirements in terms of value-adding digital health tools and
to guide the development of future mHealth interventions that
people with SCD would want to use.
Methods
Inclusion Criteria
To be part of the study, applicants had to be diagnosed with
SCD or be the caregiver of a person with SCD. Participants had
to be at least 18 years old and able to understand French or
English. People who had been cured (ie, bone marrow
transplantation) were excluded.
Recruitment
The sample for this study was a convenience sample from
Switzerland and Norway, two very low-prevalence, high-income
countries. Indeed, compared with an average in the European
Union of 2.5 cases in 10,000 people [68], these two countries
have less than approximately 1 to 4 cases per 100,000 people
[69-71] and a total of approximately 100 adult patients with
SCD. We recruited participants through the national patient
associations’ online support groups. In all, 64 individuals with
SCD were invited to participate. One week after the initial
invitation, nonresponders were sent a reminder.
Instrument
The first author (DI), an expert patient, conducted most of the
semistructured interviews using the guide presented in Table
1. The choice of an insider interviewer was made to build a
trusted, warm, and open rapport with the interviewees and to
maximize the reception of honest and open responses. In
addition, the interviewer was already familiar with some
participants. JR conducted the test interviews. Both interviewers
have many years of interview experiences. Interviews were
conducted in locations convenient and comfortable for the
participants (ie, university and private address).
The interview guide was developed previously as a joint effort
by all coauthors [67]. It was divided into five themes: (1)
preliminary questions, (2) goals, expectations, and attitudes, 3)
electronic health literacy and data integration, (4) wearables
and sensors, and (5) data sharing. Data saturation was reached
and determined by no new information emerging after
conducting interviews with all participants. Interviews were
audiotaped and lasted approximately 60 min. Questions were
open ended, and discussions were conducted flexibly. Questions
were ignored or adapted relative to the context.
Table 1. Overview of the questions asked during the interviews.
QuestionsThemes
Preliminary questions • What is most important for you in your life?
• If you had access to a new health technology, which purpose or features should it have?
Goals, expectations, and attitudes • What motivates and demotivates you to access Web-based health information?
• What are the most difficult things about your self-care?
• What could help you become more autonomous with your self-care?
Electronic health literacy and data integration • Have you ever used an app that collects health data?
• What factors would discourage you from using such an app?
Wearables and sensors • What indication would you expect from wearable sensors for health self-monitoring?
• What is the most valuable indication you would want from devices collecting your data?
Data sharing • What would you share with other patients, caregivers, and doctors and why?
• What feedback should be provided by the system?
Data Analysis
First, transcriptions of the resulting interviews were deidentified.
Second, an inductive thematic analysis was conducted using
the guidelines and checklist from Braun et al [72]. Codes were
extracted by reading the interviews recursively. Third, emerging
patterns were clustered together and checked for variability and
consistency. Themes were interpreted by reading the codes back
and forth. Once saturation was reached, themes were mapped
across the capability, opportunity, motivation, and behavior
model (COM-B), hub of the behavior change wheel (BCW)
framework [73]. The BCW is a fairly recent, theory-driven
approach that helps to design health interventions for preventive
care [73]. With the specific reading grid it provides, it allows
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us to identify barriers and enablers of engagement in any
intervention and in our particular case, to identify factors that,
if implemented together, may elicit the long-term engagement
and user adoption of mHealth apps [74-76]. Transcripts were
organized and coded using ATLAS.ti version 8.3.20.0
(ATLAS.ti Scientific Software Development GmBH, Berlin,
Germany).
Finally, to make it easier for software developers to comprehend,
themes were categorized into functional requirements (FRs)
and nonfunctional requirements (NFRs) [77]. In software
engineering, FRs are descriptions of the specific behaviors and
functions of an information system. They make explicit the
features a software should offer to the end user. In other words,
it describes what the system should do [78]. NFRs are
descriptions of how the system should operate, which is not
linked to the functionalities. To put simply, NFRs define how
the system should be (eg, responsive, intuitive, fast, and secure).
Ethics and Study Approvals
The Norwegian Regional Committees for Medical and Health
Research Ethics and the Swiss Regional Research Ethics
Committee approved the study protocol and interview questions.
As required by committees, all participants gave informed
consent before the interview, and responses were anonymized.
Results
Participant Characteristics
A total of 11 participants (7 males and 4 females) agreed to join
the study. In all, 8 patients and 3 caregivers took part in the
study, but 1 patient withdrew because of a VOC. This led to a
total of 7 patients and 3 caregivers participating in the study.
Patients were aged between 21 and 55 years. A total of 7
participants were residing in Switzerland, 3 in Norway, and 1
was partly residing in the Democratic Republic of the Congo
and in Switzerland. Table 2 presents the demographics of the
population studied.
Table 2. Distribution of characteristics of the studied sample (N=10).
ValueCharacteristics of respondents




Country of residence, n (%)
7 (70)aSwitzerlanda
3 (30)Norway
1 (10)aDemocratic Republic of the Congoa
aOne respondent was partly residing in the Democratic Republic of the Congo and in Switzerland.
Interview Results
This section shows extracted themes from the interview data.
The themes were classified into 31 FRs and 30 NFRs. We
organized them with the COM-B framework and illustrated
them with quotations from interviewees. Table 3 presents some
of the most frequent themes that appeared during interviews.
Each theme is an FR or an NFR and belongs to a COM-B system
category. In the table, themes are sorted by COM-B system
attribute, type of requirement, and then by the number of quotes.
The complete list is available in Multimedia Appendix 1.
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Table 3. Overview of potential influencers of adoption through the capability, opportunity, motivation, and behavior (COM-B) lens.
TypeCOM-B systemQuotesRequirement
FunctionalAutomatic motivation12Prevent crises by avoiding symptoms
NonfunctionalAutomatic motivation15Family and social community support (shareability)
FunctionalPhysical capability28Gain more control on disease through daily self-care support
FunctionalPhysical capability9Limit management
NonfunctionalPhysical opportunity17Importance of information trustworthiness
NonfunctionalPhysical opportunity9Invisibility or inconspicuousness
NonfunctionalPhysical opportunity8Similarity with messaging apps
NonfunctionalPhysical opportunity5Automatic reminders and automatability
NonfunctionalPhysical opportunity3Simplicity
FunctionalPsychological capability14Learn trigger factors
FunctionalPsychological capability11Predict health outcomes
FunctionalPsychological capability10Receive threshold alerts
NonfunctionalPsychological capability17Feedback on self-care practices
NonfunctionalReflective motivation8Customizable
NonfunctionalReflective motivation4Privacy
FunctionalSocial opportunity14Learn what other patients do
Physical Capability
All participants were concerned about not being able to better
predict the onset of VOCs or avoid chronic complications.
Another point to consider is that many differentiated general
daily self-management skills (ie, pain management) from
preventive care (ie, symptoms prevention). As one patient said:
It’s difficult when the situation changes in a short
time and prevents you from being active, without
warning. When suddenly you cannot do anything.
[Patient 5, 49 years]
In addition, a couple of interviewees said they would want novel
technologies that automatically regulate their hematologic
parameters (ie, hemoglobin concentration, leucocyte adherence
to vascular endothelium) [79]. Accordingly, a participant
proposed a very innovative solution:
I would like nanorobots that help my blood stay
normal, self-regulate. [Patient 9, 30 years]
Psychological Capability
The majority of participants desired to receive feedback about
SCD self-care tasks. Most emphasized the difficulty of managing
their own limits. Some wished to be warned before exceeding
their physical limitations. Namely, an interviewee proposed:
A sensor that informs me if I can go into the water
or…when I play sport, a sensor that allows me to
know what I have to limit, if there is a threshold not
to exceed. [Patient 1, 21 years]
Importantly, most of participants suggested that such warnings
should be detected with wearable sensors, releasing their
cognitive load. This can be illustrated by the following quote:
Something that shows my limitations. For example,
I would not want something that tells me 'if you go
on like this, you're going to have a crisis'. But
something configurable. Because, I like pushing my
limits. For example, when I’m walking, well... first it
must realize that I’m walking, but it could ask me how
I feel, learn my limits. [Patient 9, 30 years]
Social Opportunity
For most participants, learning about other patients’ self-care
practices was a very important concern. A majority of the
participants said they would like to share their own experiences
on digital platforms. For example, one participant said:
An indication of good health. And see what influences
what in whom. Compare what people do to feel good.
[Caregiver 1, 37 years]
Many participants stressed the importance of social support.
Some stated that mHealth could help them communicate their
needs. As one participant suggested:
Help family members to better understand the
problem, but also for crisis prevention, teach people
how to manage the disease. [Caregiver 3, 49 years]
A majority of participants reported using social media for
information sharing, communication, or entertainment. Only a
minority of them used social media to get health information.
Many participants deplored the absence of mechanisms to easily
access and control the quality of information. As one participant
said:
How to check the veracity of information sources and
information. How to demonstrate that it is validated
information. We can already see that fake news may
surpass the traditional media. So it's a sensitive topic.
[Patient 2, 37 years]
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For several interviewees, it was crucial to receive trustworthy
information. Many suggested that wearable sensors could
support this. As one participant highlighted:
Indications that support my decisions, based on sensor
data or collected data. An alert, a barometer that
allows me to refocus and would say: “be careful, be
careful, your temperature is high, your hemoglobin
is low, your CRP is high, your oxygen is low, you
should rather be at this level.” [Patient 9, 30 years]
Several participants stated that information overload would
demotivate them for long-term engagement, specifying that
mHealth apps should be as discreet as possible. Furthermore,
most participants recognized the potential usefulness of
notifications, but only if discreet and not disturbing. As one
participant stressed:
Yes, but not frequently, not something that screaming
“you're sick! you're sick!” [Patient 7, 55 years]
Notwithstanding, the majority of participants preferred user
interfaces that are simple to use and do not require a high
learning curve. Some participants believed messaging software
was the best inspiration because of its intuitive interface. As
one caregiver said:
A technology that is easy to use, user-friendly for the
digital illiterate. A system using widespread
technologies. A system, an application that has a long
life cycle. Proven technology like messaging, a simple




Importantly, a majority of the participants were not using
mHealth apps. One of the 10 participants reported using Apple
Health for menstruation management, hydration, and physical
activity management. Two participants reported using Samsung
Health for blood oxygen recording and physical activity
management. Another point to consider is that all participants
expressed a lack of specificity and adaptability to SCD
particularities in the usual health apps (ie, normal values for
people with SCD are the values indicating a disease in healthy
people). As one participant stressed:
Things should be adapted, for instance since oxygen
or arrythmia are usual for SCD. It should be adapted.
It's difficult to compare to normal people. [Patient 6,
35 years]
Privacy issues were also a fundamental concern for most
interviewees. Many feared to lose control on their data. As one
participant said:
I am not against connected devices, Cloud… I just do
not want to be found and get problems. [Patient 2, 37
years]
Finally, most participants preferred customizable information
systems. As one interviewee said:
I want to be the decision maker of what I share. I want
to control what I receive. [Patient 9, 28 years]
Automatic Motivation
The three main motivators identified were (1) strengthen social
support, (2) prevent VOC, and (3) reduce the limitations to
functioning and independent living. Regarding the first
motivator, participants wished to be able to enjoy with their
families and give back to their communities. As one participant
said:
My daughter is the most important thing in my life,
because of that, I must not forget my health. If I’m
not happy she’s not happy. [Patient 7, 55 years.]
Regarding the second motivator, all participants stated their
desire to prevent the excruciating pain crises. As one participant
said:
I want to be able to regulate, to avoid health problems
before they appear, to prevent rather than to cure.
[Patient 4, 29 years]
More importantly, most participants stressed the importance of
living as normal a life as possible and stay in good health. This
can be illustrated by the following quote:
I am particularly motivated by the desire to live well,
to be like everyone else. For my self-esteem, to show
that I am able to do the same things as a normal
person, and even better. [Patient 9, 28 years]
Discussion
Principal Findings
To the best of our knowledge, this is the first study to explore
factors that could influence the long-term engagement with
mHealth interventions of adults with SCD living in
low-prevalence, high-income countries. As a result, interviewees
described how mHealth could benefit their life and detailed
what could increase their long-term engagement and motivation
toward the mHealth app usage.
Functional Requirements in the Prism of the
Capability, Opportunity, Motivation, and Behavior
Framework
To maximize the chances of eliciting behavior change and
engagement, as many patient requirements as possible should
be implemented. In other words, providing patients with
information or alerts is not sufficient to lead to behavior change.
However, through simultaneously implementing other features
such as therapeutic education (eg lessons and accompaniment),
specifically designed wearable devices could maximize
engagement. In the following sections, we propose potential
solutions and summarize what needs to be done before being
able to develop specifically designed wearable devices.
Increasing Physical Capability: Regulate Hematological
Parameters
Patients suggested how pioneering technologies such as
blood-regulating nanorobots could inspire future pharmaceutical
research or stimulate patient-led research initiatives [80]. By
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altering hematological parameters, some innovative
pharmaceutical compounds are already aligned with patients’
suggestions [56,81]. For instance, recent clinical trials of
crizanlizumab, an antibody acting against endothelial adhesion,
have shown a significant reduction in the frequency of VOCs
[82]. However, this substance requires frequent intravenous
injections. Therefore, knowing the current underutilization of
orally administrated therapies such as hydroxyurea, intravenous
therapies bring a supplementary barrier.
In the meantime, although nonpharmaceutical strategies based
on information technologies could inform patients on how to
adapt their behaviors (ie, dietary change) to alter blood
parameters (ie hemoglobin levels, oxygen levels, and
inflammation) [83-86], novel devices, inspired from other
clinical populations, could be created. This can be illustrated
by what is happening in the Diabetes Do It Yourself (DIY)
community [87] (ie, #WeAreNotWaiting and #DIYPS). Here,
impatient patients self-organized to hack blood
glucose–monitoring system and insulin pump. They proceeded
to create a system that can, after clever calculation, automatically
inject the needed dose of insulin. In comparison, one could
foresee similar initiatives of DIY solutions supporting SCD
self-care practices. In particular, as a reminder, anemia and
oxygen desaturation are common complications among people
with SCD. As oxygen delivery by hemoglobin increases when
the number of red blood cells and the hemoglobin level
increases, one could imagine creating a closed-loop system
using a wearable hemoglobin meter or a blood oxygen meter.
This could subsequently be combined with an autoinjector filled
with ultrashort-term anemia-reducing treatments [88] (eg,
erythropoietin alpha, vitamin B12, oral folic acid, and voxelotor
[89]).
Nonetheless, it is important to consider that a significant amount
of work is required before such a system could be created and
made accurate or safe. Even if bypassing any approval from a
health authority (eg, Federal Drugs Administration), implantable
autoinjectors and specific biomonitoring devices would have
to be engineered. Then appropriate software would have to be
created to be able to analyze significant quantity of
patient-generated data. Indeed, to be accurate and effective,
such algorithm should be trained on a high quantity of data.
Afterward, the data-driven algorithm should be able to actuate
the injection of individualized doses of the adequate substances.
All of this requires a tremendous amount of skilled
bioengineering work. Another point to consider is the lower
socioeconomic status of members of the SCD community [90]
and the low awareness of SCD among the general population,
especially in high-income, low-prevalence countries. This
mechanically leads to a limited number of patient innovators
and interested independent researchers. In consequence, few
people would be skilled to build such a specialized system.
Therefore, the SCD community could start with less invasive,
less complex, but also less cognitively unloading solutions. A
simpler system could be proposed to prompt patients to ingest
relevant drugs or dietary supplements (eg, anti-inflammatory
drugs and antioxidants), after a biosensor [91] (eg, blood oxygen
and inflammation) detects a threshold. In addition, an mHealth
app could send an alert. On the one hand, medication adherence
would then become an issue to overcome, on the other, if the
medication is taken, the effect of the substance would be delayed
compared with a direct subcutaneous injection.
To summarize, the most effective solution using today’s
technology would be a closed-loop system with an autoinjector
and smart algorithm, functioning without any patient
intervention, but there is still a long and challenging way to go
before such a system could be built.
Increasing Physical Capability: Stop Pain Fast
Quick pain relief was a very important concern for most
interviewees. In the current VOC self-management, pain crises
are treated at home with oral painkillers [92,93]. When oral
drugs are no longer sufficient or when complications surge,
patients need to visit emergency departments to receive acute
care [38]. However, despite being aware of the several
challenges they would face in emergency departments (ie, long
waiting times, recurrent stigma, unrelieved pain, and prolonged
hospitalizations), many patients choose to postpone the
admission until pain becomes totally unbearable [94,95].
These challenges could partly explain why interviewees were
highly motivated by mHealth interventions that could help them
relieve their pain as fast as possible. To this end, novel sensors
and software measuring pain levels through physiological signs
or electrical signals [96] could be combined with implantable
pumps for intrathecal opioid therapy or subcutaneous injections
[97]. However, to decrease cognitive load and avoid patients to
calculate themselves how much they should inject, smart,
accurate, safe, and individualized algorithms would have to be
developed.
In the United States, one mHealth app helps children and
adolescents with SCD to inform family, physicians, or friends
about their health status [98]. Recently, innovative digital health
interventions have been deployed to facilitate emergency care
process [99]. We could also imagine apps that allow sufferers
to support and motivate each other or to come together to share
their experience of treatment efficacies [100,101]. Existing
mHealth apps for pain management could be adapted to SCD
[102]. Finally, virtual reality could be used as a new option for
pain relief through patient distraction [103].
Increasing Psychological Capability: Quality Feedback
on Self-Care Practices
The complexity of SCD self-care tasks demands various skills
(eg, high cognitive capabilities and good disease-specific
knowledge) [59]. The literature has shown that only 1% of SCD
patients were able to master them [104]. Therefore, it is easy to
understand why most interviewees desired to receive feedback
on their self-care practices.
For instance, a release of the cognitive load could be partially
decreased by using a natural user interface (eg, text, voice,
mixed reality, and augmented reality), gamification items [105],
and simple data visualization [106-109] when providing patients
with targeted information. The technology exists but needs to
be integrated, adapted, bundled, and improved [110-112].
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Inspiration could be taken from already existing systems for
people with diabetes [113,114].
Furthermore, studies have shown that behavior change
techniques for self-management such as health coaching could
improve the outcomes important for patients, such as
self-efficacy, self-management, or medication adherence, by
80% [115-118]. For instance, collecting physiological and
behavioral data, such as eating behaviors and oxygen levels,
and then automatically reporting them to an SCD expert could
allow the latter to provide advice directly in the mHealth app.
This would not require overcoming many barriers as data could
already be collected through fitness and wellness apps and
smartwatches. However, the biggest challenge lies in the
development of smart algorithms and methods to allow the
automated interpretation of such individualized and
heterogenous data [119]. In the meantime, coaching and
high-quality electronic patient decision aids could be created
to structure information and help patients make informed
decisions [120-122].
Regarding disease-specific knowledge, studies have reported
that many patients did not follow medical recommendations
[45] but may still search for health information on the Web.
When the quality of information is poor, disparities in health
information accessibility are created [123,124]. Frost et al [125]
have already discussed the promises of Web-based health
information for people with SCD, and Breakey et al [126] argued
that information was not always adequate and of good quality.
Consequently, the use of artificial intelligence [127] with
evaluation criteria, such as Health On the Net code [128] or the
DISCERN [129] framework, could facilitate the provision of
quality material to patients. Finally, content constructed with
the help of patients with SCD and using consumer health
vocabulary, simple patient language, and thesauri could improve
the communication of health information and adequacy
[130,131].
Increasing Physical Opportunity: Receive Alerts When
Reaching Own Physical Limits
Already struggling with normal life challenges, several
interviewees strongly desired help to manage the potential
triggers of VOC. However, objective laboratory, clinical,
hematological, biochemical, and rheological data are not easy
to self-monitor [41-43,132-134]. Existing noninvasive
sport-related wearable device technologies could help monitor
some markers of hematological parameters [96]. For instance,
sport watches with pulse oximeters [135], connected bottles,
oxidative stress monitor, and pH meters [136,137] could be
used. To this end, smart algorithms could be developed to
provide patients with individualized feedback.
Studies have shown that poor physical functioning was frequent
among people with SCD, making their participation in sports
difficult [138,139]. mHealth interventions specifically tailored
for physical activity support could be developed to assist people
with SCD. Accurate sensors could be integrated during physical
activity (ie, exhaustion) or after exercise (ie, recovery)
[140,141].
Increasing Social Opportunity: Learn What Other
Patients Do
One of the most reported motivational factors was the desire to
learn from other patients. This consideration is coherent with
the stigma and isolation faced by patients with SCD living in
low endemic areas [142]. This concern is also consistent with
the general lack of educational interventions [143] and the
limited availability of specialized health care providers [144].
It is well known that patients with a chronic disease hold
nonnegligible experiential knowledge (eg, effective dietary
supplements and where to find them, tips) and often share it on
social networks [145-147]. However, the knowledge available
on these platforms is difficult to extract, the quality is difficult
to guarantee, and the information is often unstructured, hence
difficult to mine [148].
Well-funded and organized social networks such as Patients
Like Me or Diabetes online support groups (eg, TuDiabetes,
glu, and Diabetes Daily) could serve as inspiration to structure
patients’ experiential knowledge [149]. However, in comparison
to the total SCD population, few patients with SCD use online
support groups. A study by Ragnedda et al [150] has
demonstrated that socially disadvantaged groups (eg, gender,
ethnicity, and disability) tended to use the internet less than
more advantaged groups. Conversely, a study by Issom et al
[151] suggests that patients with SCD would be willing to use
such online support groups if the quality of information is
ensured and if it is specifically tailored for people with SCD.
Consequently, SCD-specific online support groups such as
OneSCDVoice [152] could be turned into persuasive social
networks with questions and answers, ensuring the medical
accuracy of patients’ shared experiences [153]. In addition,
artificial intelligence techniques could be used to help detect
low-quality information [154]. Another issue is the multitude
of SCD online support groups (eg, hundreds of Facebook groups
and various websites). This spreads the information, fragments
messages, and complicates access to experiential knowledge.
In addition, as people with SCD and their caregivers have low
educational levels [61], their organizational skills and digital
literacy are reduced, subsequently hindering their access to
online health information.
Main Motivations: Live a Normal Life and Learn to
Avoid Symptoms
A majority of participants stated that their highest motivation
would be to be asymptomatic. When bone marrow transplant
is not possible, or when hydroxyurea does not significantly
reduce symptom frequency, alternative treatment options such
as self-management interventions, chronic transfusions, or red
blood cells exchange could be proposed [155]. Transfusions
have shown to significantly reduce the frequency of VOCs but
require high quantities of rare phenotype blood. In addition,
phenotype matching is difficult in high-income, low-prevalence
areas. Self-management interventions require a high level of
self-efficacy. Electronic patient decisions aids (ePtDAs) could
be helpful. Indeed, ePtDAs have proven effective in engaging
patients in self-care processes and helping patients choose
alternative treatment options [156]. To date, there are no such
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tools for SCD. However, a study by Kulandaivelu et al [157]
showed that people with SCD asked for such help.
To push for the development of such systems, patients would
require to be more aware of novel treatment options, innovative
solutions, or self-management support possibilities. As a result,
they could better organize to create awareness among potential
payers (eg, philanthropists and pharmaceutical companies) who
could help finance the development of such advanced solutions.
However, this remains a challenge for the socioeconomically
disadvantaged majority of people with SCD [61].
Nonfunctional Requirements
This section discusses the most frequently reported NFRs by
the interviewees. NFRs important for the patients are crucial
when developing software [158]. A mismatch between them
and the final product could lead to low adoption rates and
discourage app usage.
Automatability
Participants clearly preferred automatic health data acquisition
rather than manual data entry. To date, there is no SCD-specific
mHealth intervention using automated data capture. However,
data from electronic health records, smartphone sensors, or
wearable devices [159] could be automatically collected in
future mHealth interventions for people with SCD [160].
Invisibility
Invisibility or inconspicuousness is the ability of a system not
to attract attention. As many interviewees reported and
consistent with existing literature [161], mHealth interventions
are more likely to be adopted if they clearly reduce the
inconvenience and burden of self-management tasks, while
being discreet. Indeed, bulky and inelegant wearable devices
could indicate to other people that wearer has a disease.
Implantable devices, discreet patches, and wearables with subtle
design or integrable into daily life objects (eg, contact lenses,
implants, and bottles) could be preferred [162-165].
Similarity With Messaging Apps
More than half of the respondents called for an mHealth
intervention that provides a user experience similar to that
provided by the apps they are using the most (ie, messaging
apps). Only few studies have explored conversational designs
for mHealth interventions. However, some conversational user
interfaces have been successfully used to reduce obesity or as
support for mental health interventions [166,167]. Such systems
have been already shown to encourage behavior changes and
have high levels of acceptability. This could encourage similar
designs in future studies for patients with SCD.
Shareability
In the context of Web-based health information, shareability
[168] is the capacity of patient-generated health data to be shared
with third parties. By allowing patients to share their knowledge,
mHealth apps could highlight valuable information that
clinicians cannot offer [169] and ease social support [170]. As
for people with rare diseases, question and answer social
networks [171] could be leveraged [172].
Privacy
In the mHealth context, privacy is the ability of a patient to
protect information about their medical condition [173]. Being
aware of the rarity of SCD in their countries, interviewees were
particularly attentive to this issue. Participants emphasized that
control should be given on what they share and to whom. Studies
for other chronic diseases showed that privacy is a very
important aspect [174]. Answering this concern by taking into
account regulations (ie, General Data Protection Regulation and
Health Insurance Portability and Accountability Act) when
designing mHealth interventions would be key to reduce poor
adoption [175]. Here, existing compliant data management
platforms with dynamic consent management [176] or personal
data cooperatives [177] could be used. Furthermore, novel
deidentification approaches could help implement this NFR
important for the patients [178].
Customizability
To maximize acceptability and inconspicuousness, most
participants proposed the customization of the timing of delivery
of push notifications. This finding is aligned with a study by
Morrison et al [179] suggesting that notifications with tailored
timing could enhance exposure to mHealth interventions.
However, several patients stressed their dislike of recurrent
notifications (ie, water intake), saying it would remind them of
their disease. This is aligned with a study by Bidargaddi et al
[180] suggesting that notifications should be sent at midday or
on weekends. The truth probably lies in between, where a system
could allow patients to choose from a range of predefined
settings.
Finally, as the interviews demonstrated, patients did not think
that existing health apps where adapted to their needs. As a
result, any new digital health solution for people with SCD
should include patients in every phase of the development and
focus on SCD particularities. Finally, the developed system
should be strongly marketed as a patient-centered solution.
Lessons Learned
Our findings highlighted the participants’ very clear expectations
toward mHealth apps. Respondents seemed undeniably
motivated to use an invisible technology that would accompany
their self-care practices (ie, personalized feedback). Participants
were very critical toward privacy issues and information quality.
Given the numerous and complex day-to-day self-care
management tasks that patients with SCD face and taking into
account the isolation of living in low-prevalence, high-income
countries, it appears that, in order to get long-term engagement
and adoption, mHealth apps must add clear value and be
particularly tailored to patients’ needs.
From Requirements to Successful Implementation
For such an mHealth solution to have an impact once
implemented, quality and perceived value must be distinguished.
However, the digital health world still lacks a standardized
mechanism for health app quality evaluation and certification
[181]. There is no consensus for guidelines, nor clear criteria
to help recognize what a quality mHealth app is. For instance,
people with diabetes, with more than 300 apps on the Google
Play Store, can easily struggle to find what apps they should
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download. Some app curation websites [182] help end users to
find health apps ranked by quality. However, the analytic
methods vary for each website. For instance, in the United
Kingdom, the National Health Service Digital and National
Institute for Health and Care Excellence has chosen clinical
effectiveness, regulatory approval, clinical safety, privacy and
confidentiality, security, usability and accessibility,
interoperability, technical stability, and change management as
criteria. Other websites could use other criteria, for instance
apps for which there is published medical evidence.
As a result, app developers should make an effort to meet
requirements important for the patients and thrive to meet as
many quality indicators as possible. This can be summarized
with the following steps:
• Take a patient-centered approach: make sure the app
improves patient outcomes; and the app is validated in terms
of clinical outcomes.
• Offer a real solution to self-management problems faced
by patients: the app should meet patients’ requirements and
do better than any alternative and should be cheaper.
• Be compatible with the existing health care information
system infrastructure: implement interoperability standards
by design; and answer privacy and safety requirements.
Key Points
Nevertheless, it is clear that there is no invisible technology yet
to support the self-care practices of patients with SCD. However,
the various technological pieces needed to build such a
ubiquitous system are largely available today. Nonetheless, they
are scattered, not bundled nor adapted to the specificity of SCD.
The following steps summarize what needs to be done before
implementing the key requirements:
• Disease-modifying functionalities (ie, pain relief and
regulation of hematological variables) to reduce poor
adoption rates by providing patients with continuous blood
oxygen meters, specific autoinjectors, and smart software
that includes algorithms that are able to manage and make
sense of the big datasets generated.
• Targeted information (eg, alerts when approaching limits
and access to other patients’ self-care practices) could
influence the long-term engagement by providing patients
with knowledge adapted to their health literacy levels, user
interface matching their digital literacy levels, and
information adapted to their disease-specific knowledge,
and if necessary, offer assistance to interpret the
information.
• Controlling data flows (eg, shareability, privacy, and quality
information) could influence patients’ motivation to start
using apps by storing data on personal data cooperatives,
implementing existing interoperable standards, using
algorithms, and hiring content moderators (eg, physicians
and expert patients) to monitor content creation and the
quality of information.
Future Plans
Given the complexity of SCD self-management, supporting
self-care needs important for the patients using mHealth
interventions will be challenging. However, such systems will
be key to fill the gaps in health care delivery service. Further
work is needed to implement patient requirements. Prioritization
could be done using participatory approaches. Tools such as
the APEASE (Affordability, Practicability,
Effectiveness/cost-effectiveness, Acceptability,
Side-effects/safety, Equity) criteria, a set of benchmarks from
the BCW framework, can be helpful to decide what content
should be included and what intervention delivery strategies
should be used. In addition to proven added value with the
effective implementation of requirements important for the
patients, other NFRs include affordability, practicability,
effectiveness and cost-effectiveness, acceptability, side effects,
safety, and equity.
In addition, Delphi surveys [183], a technique consisting of
seeking experts’ views to obtain a level of agreement by
transforming opinion into group consensus, could be sent to
expert patients [121,184].
Finally, motivational factors will have to be assessed in the long
run to maintain high user engagement levels. This could be done
using tailored frameworks for mHealth engagement analysis
such as the Analyzing and Measuring Usage and Engagement
Data framework [185].
Strengths and Limitations
The study has a number of strengths and limitations. Using the
COM-B model to identify motivational factors is a relatively
recent approach in the field of mHealth. However, in this
example, the lens offered by the model was helpful to gain a
full picture of patients’ motivations. In addition, this model
allowed us to classify patient requirements into explicit
categories and helped us to discuss potentially useful
technologies to meet patients’ unmet needs.
The age range of the sample was large; consequently, younger
patients may feel more comfortable using digital health
interventions than older ones. In addition, our sample size
approximates 10% of the adults with SCD living in the selected
low-prevalence, high-income countries. Also, because of the
notorious difficulty in enrolling patients with SCD in studies,
we were surprised by this relatively high response rate. The fact
that the main interviewer was an expert patient may have eased
enrollment and facilitated trust building but also added a bias.
Finally, the study results could be affected by the recruitment
criteria. As participants were selected inside an active SCD
community, it is possible that those who volunteered to be
interviewed were more in search of new coping solutions and
had more positive views about the disease than those who
declined or did not replied.
Conclusions
As interviewees were particularly explicit in what could benefit
them, this study provides initial insights on how to build
mHealth apps that could engage particularly isolated SCD
populations. The use of qualitative methods enabled in-depth
exploration of interviewees’ responses. Furthermore, the BCW
and, its hub, the COM-B model could be used as a robust
framework to inform the development of future persuasive
technologies for people with SCD. As patients highlighted,
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future research should focus on supporting their self-care
decisions. Exploring the integration, adaption, or improvement
of highly adopted mHealth interventions for other chronic
diseases could be helpful.
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